Vanda Pharmaceuticals
VNDA
S$6.03
Share price
-0.43%
Change (1 day)
-25.16%
Change (1 year)
Categories
Operating Margin for Vanda Pharmaceuticals (VNDA)
Operating Margin as of July 2025 (TTM): -35.98%
According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -35.98%. At the end of 2024 the company had an Operating Margin of -11.53%.
Operating Margin history for Vanda Pharmaceuticals from 2010 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -11.53% | -450.43% |
| 2023 | 3.29% | -25.92% |
| 2022 | 4.44% | -71.83% |
| 2021 | 15.77% | 23.61% |
| 2020 | 12.76% | -0.17% |
| 2019 | 12.78% | -2.65% |
| 2018 | 13.12% | -240.41% |
| 2017 | -9.35% | -23.78% |
| 2016 | -12.26% | -66.19% |
| 2015 | -36.27% | -190.11% |
| 2014 | 40.25% | -164.76% |
| 2013 | -62.15% | -28.93% |
| 2012 | -87.44% | 166.86% |
| 2011 | -32.77% | -224.5% |
| 2010 | 26.32% | -103.34% |
| 2009 | -788.46% | |
| 2004 | -27,867.38% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 28.02% | -177.88% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 27.75% | -177.13% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 18.78% | -152.20% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 12.82% | -135.63% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -135.02% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | -556,900.00% | 1,547,704.34% | 🇺🇸 USA |
 Merck MRK | 31.06% | -186.33% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.